We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-0.56%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$15.7B
AUM Growth
-$1.33B
(-7.8%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
173
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$70.7M |
| 2 |
Meta Platforms (Facebook)
META
|
+$66.5M |
| 3 |
Becton Dickinson
BDX
|
+$61.6M |
| 4 |
GitLab
GTLB
|
+$58.7M |
| 5 |
Teradyne
TER
|
+$58.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$85.2M |
| 2 |
Steris
STE
|
+$78.2M |
| 3 |
CVS Health
CVS
|
+$62.9M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$61.9M |
| 5 |
FIVE9
FIVN
|
+$58.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.08% |
| 2 | Industrials | 22.24% |
| 3 | Healthcare | 19.2% |
| 4 | Financials | 15.72% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACH
301
Accendra Health
ACH
$86.1M
| $515K | ﹤0.01% |
21,388
+6,500
| +44% | +$200K |
|
302
A.O. Smith
AOS
$7.8B
| $506K | ﹤0.01% |
10,415
+47
| +0.5% | +$2.7K |
|
303
Gentex
GNTX
$4.8B
| $504K | ﹤0.01% |
21,147
-4,023
| -16% | -$110K |
|
304
QuidelOrtho
QDEL
$808M
| $494K | ﹤0.01% |
6,910
+2,435
| +54% | +$218K |
|
305
Organon & Co
OGN
$3.58B
| $493K | ﹤0.01% |
21,058
| – | – |
|
306
Itron
ITRI
$4.02B
| $488K | ﹤0.01% |
11,595
-23,000
| -66% | -$1.15M |
|
|
APLS
307
DELISTED
Apellis Pharmaceuticals
APLS
| $471K | ﹤0.01% |
6,900
| – | – |
|
308
Repligen
RGEN
$9.48B
| $468K | ﹤0.01% |
+2,500
| New | +$527K |
|
309
Enovix
ENVX
$663M
| $449K | ﹤0.01% |
28,009
-1,432
| -5% | -$21.1K |
|
|
MDRX
310
DELISTED
Veradigm Inc. Common Stock
MDRX
| $424K | ﹤0.01% |
27,855
+16,775
| +151% | +$271K |
|
311
Arrowhead Research
ARWR
$11.4B
| $415K | ﹤0.01% |
12,547
-4,635
| -27% | -$187K |
|
312
Lyft
LYFT
$6.02B
| $412K | ﹤0.01% |
31,251
+6,537
| +26% | +$101K |
|
313
KE Holdings
BEKE
$18.4B
| $403K | ﹤0.01% |
23,010
-5,211
| -18% | -$84.4K |
|
314
Sunrun
RUN
$2.01B
| $385K | ﹤0.01% |
13,965
| – | – |
|
315
Allegro MicroSystems
ALGM
$6.31B
| $374K | ﹤0.01% |
17,136
-2,897
| -14% | -$67.2K |
|
|
BLDP
316
Ballard Power Systems
BLDP
$651M
| $352K | ﹤0.01% |
46,585
-4,666
| -9% | -$34.9K |
|
|
FSR
317
DELISTED
Fisker Inc.
FSR
| $351K | ﹤0.01% |
46,445
-4,644
| -9% | -$41.9K |
|
318
Acuity Brands
AYI
$9.55B
| $343K | ﹤0.01% |
2,176
+1
| +0% | +$169 |
|
|
NATI
319
DELISTED
National Instruments Corp
NATI
| $331K | ﹤0.01% |
8,779
+61
| +0.7% | +$2.31K |
|
320
EVgo
EVGO
$205M
| $327K | ﹤0.01% |
41,382
-4,155
| -9% | -$36.2K |
|
321
Establishment Labs
ESTA
$2.14B
| $322K | ﹤0.01% |
5,891
| – | – |
|
322
Ormat Technologies
ORA
$5.66B
| $322K | ﹤0.01% |
3,730
+4
| +0.1% | +$356 |
|
|
ALTR
323
DELISTED
Altair Engineering Inc
ALTR
| $317K | ﹤0.01% |
7,164
-1,162
| -14% | -$60.9K |
|
324
Lumentum
LITE
$74.9B
| $314K | ﹤0.01% |
4,586
| – | – |
|
325
Silicon Laboratories
SLAB
$7.35B
| $300K | ﹤0.01% |
2,432
| – | – |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q3 2022 Portfolio in Review
As of Q3 2022, Polar Capital Holdings held 471 positions worth $15.7B, down 7.8% from $17B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Polar Capital Holdings's Q3 2022 filing shows 38 new, 139 increased, 173 reduced and 54 closed positions. Its largest new stake was DexCom: 834,956 shares worth $67.2M. The largest sale was Adobe, an estimated $85.2M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.
- Polar Capital Holdings's largest Q3 2022 buy was DexCom: 834,956 shares worth $67.2M.
- Polar Capital Holdings added most to Meta Platforms (Facebook) in Q3 2022, an estimated $66.5M increase.
- Polar Capital Holdings's biggest Q3 2022 reduction was Neurocrine Biosciences, cutting an estimated $61.9M.
- Polar Capital Holdings fully exited Adobe in Q3 2022, selling an estimated $85.2M.
- Polar Capital Holdings's ten largest holdings make up 40% of its $15.7B portfolio in Q3 2022.
- Polar Capital Holdings opened 38 new positions and closed 54 in Q3 2022.
- Polar Capital Holdings's portfolio value fell 7.8% quarter-over-quarter to $15.7B.
Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.